Enhance Immunoprevention by Blocking Early Expansion of Suppressive Myeloid Cells - Supplement Proposal
通过阻止抑制性骨髓细胞的早期扩增来增强免疫预防 - 补充提案
基本信息
- 批准号:10281851
- 负责人:
- 金额:$ 25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-15 至 2022-03-14
- 项目状态:已结题
- 来源:
- 关键词:AwardCD4 Positive T LymphocytesCellsData SetDiseaseErythroplasiaExcisionExhibitsGenetically Engineered MouseGenomicsHead and Neck CancerHistologicImmuneImmunologic SurveillanceImmunologicsImmunooncologyImmunopreventionInfiltrationIntraepithelial NeoplasiaLeadLesionMalignant - descriptorMalignant NeoplasmsMetabolicModelingMorbidity - disease rateMucous MembraneMyeloid-derived suppressor cellsOperative Surgical ProceduresOralOral LeukoplakiaParentsPatientsPreventionRegimenTimeeffective therapyhead and neck cancer patienthigh riskhigh risk populationhuman diseaseimmune checkpoint blockadeloss of functionnew technologynoveloral cavity epitheliumorofacialparent projectpremalignantprogramspublic health relevancesingle-cell RNA sequencingtumor-immune system interactions
项目摘要
PROJECT SUMMARY
Immune checkpoint blockade has proven an effective treatment for a subset of head and neck cancer
(HNC) patients. However, over 85% of the patients cannot benefit from this strategy, largely due to the highly
immunosuppressive tumor microenvironment (TME) in established cancers. Oral leukoplakias / Oral Epithelial
Dysplasias (OEDs) precede HNC and offer a unique time window for disease eradication. However, surgical
resection in the orofacial region results in significant morbidity and function loss, and more importantly, cannot
reverse field cancerization. A subset of OEDs transform into malignancy despite vigilant follow-ups. Frequent
immune cell infiltration is a common feature of OEDs, however, little is known about when and how OEDs
evade from immuno-surveillance and reach a point-of-no-return. Through the support of the parent award, we
constructed unique genetically engineered mouse models, which can model a spectrum of OED/HNC lesions
with high-fidelity histologic and immunophenotypic resemblance to human diseases. In this supplement, two
immunoprevention teams within the Immuno-Oncology Translational Network will integrate a recently
developed immune profiling analytical pipeline for single-cell RNA-Seq data sets to assess the prevention
effects of a novel combination, which aims to mitigate the early expansion of suppressive myeloid cells and to
enrich effector CD4+ T-cells. The new technologies developed through the supplement will strengthen the two
parent projects and inform new promising immunoprevention assets for genetically high-risk OEDs.
项目摘要
免疫检查点阻断已被证明是一种有效的治疗头颈部癌症的方法
(HNC)患者然而,超过85%的患者不能从这种策略中受益,主要是由于高度的
免疫抑制肿瘤微环境(TME)在已建立的癌症中的作用。口腔白斑/口腔上皮
发育不良(OED)先于HNC,为疾病根除提供了独特的时间窗。然而,手术
口面区域的切除导致显著的发病率和功能丧失,更重要的是,
反向场癌变。一个子集的OED转化为恶性肿瘤,尽管警惕后续。频繁
免疫细胞浸润是OEDs的一个共同特征,然而,关于OEDs何时以及如何浸润却知之甚少。
逃避免疫监视,走上不归路通过家长奖的支持,我们
构建了独特的基因工程小鼠模型,可以模拟一系列OED/HNC病变
在组织学和免疫表型上与人类疾病高度相似。在这篇文章中,两个
免疫肿瘤转化网络内的免疫预防团队将在最近整合一个
为单细胞RNA-Seq数据集开发免疫分析管道,以评估预防
一种新的组合,其目的是减轻抑制性骨髓细胞的早期扩增,
富集效应CD 4 + T细胞。通过补充开发的新技术将加强这两个
父项目,并为遗传高风险OED提供新的有前途的免疫预防资产。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Chadwick Brenner其他文献
John Chadwick Brenner的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Chadwick Brenner', 18)}}的其他基金
Robust Immuno-prevention Strategies for High-Risk Oral Epithelial Dysplasia
针对高风险口腔上皮发育不良的强有力的免疫预防策略
- 批准号:
10384385 - 财政年份:2021
- 资助金额:
$ 25万 - 项目类别: